Premium
The incretin effect, GLP‐1 analogues and DPP‐4 inhibitors
Author(s) -
Banham Stephen
Publication year - 2011
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.817
Subject(s) - incretin , medicine , type 2 diabetes , pharmacology , dipeptidyl peptidase 4 , action (physics) , glucagon like peptide 1 , diabetes mellitus , endocrinology , physics , quantum mechanics
In this short article, the author explains the reduced ‘incretin effect’ in type 2 diabetes and the mode of action of GLP‐1 analogues and DPP‐4 inhibitors. Copyright © 2011 Wiley Interface Ltd
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom